Literature DB >> 29531625

Clearing up potential misconceptions about the treatment of rheumatoid arthritis and the use of methotrexate in combination therapy.

Cecli Zenuk1.   

Abstract

Entities:  

Year:  2018        PMID： 29531625      PMCID： PMC5843120          DOI： 10.1177/1715163518756679

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  25 in total

1.  Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring.

Authors:  Janet A Butler; Robert C Peveler; Paul Roderick; Robert Horne; Juan C Mason
Journal:  Transplantation       Date:  2004-03-15       Impact factor: 4.939

2.  A large-scale validation study of the Medication Adherence Rating Scale (MARS).

Authors:  Laura Fialko; Philippa A Garety; Elizabeth Kuipers; Graham Dunn; Paul E Bebbington; David Fowler; Daniel Freeman
Journal:  Schizophr Res       Date:  2007-12-20       Impact factor: 4.939

3.  Practice guidelines for pharmacists: The pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Authors:  Carolyn Bornstein; Marie Craig; Diane Tin
Journal:  Can Pharm J (Ott)       Date:  2014-03

4.  Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Authors:  Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; C F Allaart; D van Zeben; P J S M Kerstens; J M W Hazes; A H Zwinderman; H K Ronday; K H Han; M L Westedt; A H Gerards; J H L M van Groenendael; W F Lems; M V van Krugten; F C Breedveld; B A C Dijkmans
Journal:  Arthritis Rheum       Date:  2005-11

5.  Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Authors:  Vivian P Bykerk; Pooneh Akhavan; Glen S Hazlewood; Orit Schieir; Anne Dooley; Boulos Haraoui; Majed Khraishi; Sharon A Leclercq; Jean Légaré; Diane P Mosher; James Pencharz; Janet E Pope; John Thomson; Carter Thorne; Michel Zummer; Claire Bombardier
Journal:  J Rheumatol       Date:  2011-09-15       Impact factor: 4.666

6.  Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research.

Authors:  A Kleinman; L Eisenberg; B Good
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

7.  Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.

Authors:  R F van Vollenhoven; S Ernestam; P Geborek; I F Petersson; L Cöster; E Waltbrand; A Zickert; J Theander; A Thörner; H Hellström; A Teleman; C Dackhammar; F Akre; K Forslind; L Ljung; R Oding; A Chatzidionysiou; M Wörnert; J Bratt
Journal:  Lancet       Date:  2009-08-08       Impact factor: 79.321

Review 8.  Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.

Authors:  Glen S Hazlewood; Cheryl Barnabe; George Tomlinson; Deborah Marshall; Daniel J A Devoe; Claire Bombardier
Journal:  Cochrane Database Syst Rev       Date:  2016-08-29

Review 9.  Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review.

Authors:  Rishi J Desai; Kylie J Thaler; Peter Mahlknecht; Gerald Gartlehner; Marian S McDonagh; Bita Mesgarpour; Alireza Mazinanian; Anna Glechner; Chandrasekar Gopalakrishnan; Richard A Hansen
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-08       Impact factor: 4.794

Review 10.  Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update.

Authors:  Michaela A Stoffer; Monika M Schoels; Josef S Smolen; Daniel Aletaha; Ferdinand C Breedveld; Gerd Burmester; Vivian Bykerk; Maxime Dougados; Paul Emery; Boulos Haraoui; Juan Gomez-Reino; Tore K Kvien; Peter Nash; Victoria Navarro-Compán; Marieke Scholte-Voshaar; Ronald van Vollenhoven; Désirée van der Heijde; Tanja A Stamm
Journal:  Ann Rheum Dis       Date:  2015-05-19       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.